Austria is set to finance Iran’s developing nuclear hospital

By Catherine Sturman
Share
It has recently been reported that Austria is set to significant financial investment in the construction of Iran’s first nuclear hospital. Upon the...

It has recently been reported that Austria is set to significant financial investment in the construction of Iran’s first nuclear hospital.

Upon the €1 billion signing with Austria's Oberbank, it will now provide US$248mn to the project, where the new facility will house up to a thousand beds and enable the region to further cater to patients in the need of nuclear medicines or treatment.

“One of the most important stages of getting the project underway was its financial aspect. The hospital needs €200 million worth of equipment, which is being provided by the Austrian banks,” Iran's Spokesman Behrouz Kamalvandi explained.

See also

Upon the signing of an MoU with the health ministry, the development of the hospital will be one of the largest of its kind in the Middle East and will provide world-class radiotherapy services. Installing essential diagnosis and technologies to support patient recovery from a number of diseases.

The hospital will join the 150 nuclear medicine facilities across the Middle East, such as The nuclear medicine centre at Namazi Hospital in Shiraz, Fars Province, where new methods and treatments to support patient recovery are being explored.

"Plans have been developed to turn the Islamic Republic of Iran into a radiopharmaceutical manufacturing hub in the Middle East with the lifting of the sanctions,” Mehdi Pirsalehi, Head of The Health Ministry’s Drugs Supervision Office said.

Once completed, Austria will receive payments from the hospital’s revenue stream.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma